Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms' tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia

References

• Bruchova H, Kalinova M, Brdicka R. Array-based analysis of gene expression in childhood acute lymphoblastic leukemia. Leuk Res 2004; 28: 1–7
   PubMed Web of Science ®Google Scholar
• Kuchinskaya E, Heyman M, Grander D, Linderholm M, Soderhall S, Zaritskey A, et al. Children and adults with acute lymphoblastic leukaemia have similar gene expression profiles. Eur J Haematol 2005; 74: 466–480
   PubMed Web of Science ®Google Scholar
• Moos P J, Raetz E A, Carlson M A, Szabo A, Smith F E, Willman C, et al. Identification of gene expression profiles that segregate patients with childhood leukemia. Clin Cancer Res 2002; 8: 3118–3130
   PubMed Web of Science ®Google Scholar
• Armstrong S A, Staunton J E, Silverman L B, Pieters R, den Boer M L, Minden M D, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41–47
   PubMed Web of Science ®Google Scholar
• Ebert B L, Golub T R. Genomic approaches to hematologic malignancies. Blood 2004; 104: 923–932
   PubMed Web of Science ®Google Scholar
• Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W, et al. Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. Leukemia 2004; 18: 63–71
   PubMed Web of Science ®Google Scholar
• Ross M E, Zhou X, Song G, Shurtleff S A, Girtman K, Williams W K, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 2003; 102: 2951–2959
   PubMed Web of Science ®Google Scholar
• Willenbrock H, Juncker A S, Schmiegelow K, Knudsen S, Ryder L P. Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays. Leukemia 2004; 18: 1270–1277
   PubMed Web of Science ®Google Scholar
• Yeoh E J, Ross M E, Shurtleff S A, Williams W K, Patel D, Mahfouz R, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133–143
   PubMed Web of Science ®Google Scholar
• Shawver L K, Slamon D, Ullrich A. Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 2002; 1: 117–123
   PubMed Web of Science ®Google Scholar
• Becker J C, Muller-Tidow C, Serve H, Domschke W, Pohle T. Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy. World J Gastroenterol 2006; 12: 3297–3305
   PubMed Web of Science ®Google Scholar
• Meshinchi S, Stirewalt D L, Alonzo T A, Zhang Q, Sweetser D A, Woods W G, et al. Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia. Blood 2003; 102: 1474–1479
   PubMed Web of Science ®Google Scholar
• Stirewalt D L, Radich J P. The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer 2003; 3: 650–665
   PubMed Web of Science ®Google Scholar
• Forrester W C, Dell M, Perens E, Garriga G. A.C. elegans Ror receptor tyrosine kinase regulates cell motility and asymmetric cell division. Nature 1999; 400: 881–885
   PubMed Web of Science ®Google Scholar
• Masiakowski P, Carroll R D. A novel family of cell surface receptors with tyrosine kinase-like domain. J Biol Chem 1992; 267: 26181–26190
   PubMed Web of Science ®Google Scholar
• Reddy U R, Phatak S, Allen C, Nycum L M, Sulman E P, White P S, et al. Localization of the human Ror1 gene (NTRKR1) to chromosome 1p31-p32 by fluorescence in situ hybridization and somatic cell hybrid analysis. Genomics 1997; 41: 283–285
   PubMed Web of Science ®Google Scholar
• Reddy U R, Phatak S, Pleasure D. Human neural tissues express a truncated Ror1 receptor tyrosine kinase, lacking both extracellular and transmembrane domains. Oncogene 1996; 13: 1555–1559
   PubMed Web of Science ®Google Scholar
• Matsuda T, Nomi M, Ikeya M, Kani S, Oishi I, Terashima T, et al. Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development. Mech Dev 2001; 105: 153–156
   PubMed Web of Science ®Google Scholar
• Nomi M, Oishi I, Kani S, Suzuki H, Matsuda T, Yoda A, et al. Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinases. Mol Cell Biol 2001; 21: 8329–8335
   PubMed Web of Science ®Google Scholar
• Paganoni S, Ferreira A. Neurite extension in central neurons: a novel role for the receptor tyrosine kinases Ror1 and Ror2. J Cell Sci 2005; 118: 433–446
   PubMed Web of Science ®Google Scholar
• Klein U, Tu Y, Stolovitzky G A, Mattioli M, Cattoretti G, Husson H, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001; 194: 1625–1638
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Alizadeh A A, Widhopf G, Simon R, Davis R E, Yu X, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639–1647
   PubMed Web of Science ®Google Scholar
• Boublikova L, Kalinova M, Ryan J, Quinn F, O'Marcaigh A, Smith O, et al. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring. Leukemia 2006; 20: 254–263
   PubMed Web of Science ®Google Scholar
• Cilloni D, Gottardi E, Saglio G. WT1 overexpression in acute myeloid leukemia and myelodysplastic syndromes. Methods Mol Med 2006; 125: 199–211
   PubMedGoogle Scholar
• Nakatsuka S, Oji Y, Horiuchi T, Kanda T, Kitagawa M, Takeuchi T, et al. Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 2006; 19: 804–814
   PubMed Web of Science ®Google Scholar
• Scholz H, Kirschner K M. A role for the Wilms' tumor protein WT1 in organ development. Physiology (Bethesda) 2005; 20: 54–59
   PubMed Web of Science ®Google Scholar
• Haber D A, Housman D E. Role of the WT1 gene in Wilms' tumour. Cancer Surv 1992; 12: 105–117
   PubMedGoogle Scholar
• Siehl J M, Reinwald M, Heufelder K, Menssen H D, Keilholz U, Thiel E. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants. Ann Hematol 2004; 83: 745–750
   PubMed Web of Science ®Google Scholar
• Chiusa L, Francia di Celle P, Campisi P, Ceretto C, Marmont F, Pich A. Prognostic value of quantitative analysis of WT1 gene transcripts in adult acute lymphoblastic leukemia. Haematologica 2006; 91: 270–271
   PubMed Web of Science ®Google Scholar
• Olszewski M, Huang W, Chou P M, Duerst R, Kletzel M. Wilms' tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action?. Cytotherapy 2005; 7: 57–61
   PubMed Web of Science ®Google Scholar
• Han X, Bueso-Ramos C E. Advances in the pathological diagnosis and biology of acute lymphoblastic leukemia. Ann Diagn Pathol 2005; 9: 239–257
   PubMedGoogle Scholar
• Gharagozlou S, Ghods R, Bahrami Z S, Roohi A, Jeddi-Tehrani M, Conti-Fine B M, et al. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII. Hum Antibodies 2003; 12: 67–76
   PubMedGoogle Scholar
• Shibuya H, Nagai T, Ishii A, Yamamoto K, Hirohata S. Differential regulation of Th1 responses and CD154 expression in human CD4+ T cells by IFN-alpha. Clin Exp Immunol 2003; 132: 216–224
   PubMed Web of Science ®Google Scholar
• Asgarian Omran H, Shabani M, Shahrestani T, Sarafnejad A, Khoshnoodi J, Vossough P, et al. Immunophenotypic subtyping of leukemic cells from Iranian patients with acute lymphoblastic leukaemia: association to disease outcome. Iran J Immunol 2007; 4: 15–25
   PubMedGoogle Scholar
• Hokland P, Ritz J, Schlossman S F, Nadler L M. Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells. J Immunol 1985; 135: 1746–1751
   PubMed Web of Science ®Google Scholar
• Foon K A, Todd RF I II. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1–31
   PubMed Web of Science ®Google Scholar
• Walsh S H, Rosenquist R. Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis. Med Oncol 2005; 22: 327–341
   PubMed Web of Science ®Google Scholar
• Bene M C. Immunophenotyping of acute leukaemias. Immunol Lett 2005; 98: 9–21
   PubMed Web of Science ®Google Scholar
• Campana D, Behm F G. Immunophenotyping of leukemia. J Immunol Methods 2000; 243: 59–75
   PubMed Web of Science ®Google Scholar
• Cario G, Stanulla M, Fine B M, Teuffel O, Neuhoff N V, Schrauder A, et al. Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia. Blood 2005; 105: 821–826
   PubMed Web of Science ®Google Scholar
• Hunger S P. Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood 1996; 87: 1211–1224
   PubMed Web of Science ®Google Scholar
• Su A I, Welsh J B, Sapinoso L M, Kern S G, Dimitrov P, Lapp H, et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 2001; 61: 7388–7393
   PubMed Web of Science ®Google Scholar
• De Pitta C, Tombolan L, Campo Dell'Orto M, Accordi B, te Kronnie G, Romualdi C, et al. A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia. Haematologica 2005; 90: 890–898
   PubMedGoogle Scholar
• Im H J, Kong G, Lee H. Expression of Wilms tumor gene (WT1) in children with acute leukemia. Pediatr Hematol Oncol 1999; 16: 109–118
   PubMed Web of Science ®Google Scholar
• Kletzel M, Olzewski M, Huang W, Chou P M. Utility of WT1 as a reliable tool for the detection of minimal residual disease in children with leukemia. Pediatr Dev Pathol 2002; 5: 269–275
   PubMed Web of Science ®Google Scholar
• Magyarosy E, Varga N, Timar J, Raso E. Follow-up of minimal residual disease in acute childhood lymphoblastic leukemia by WT1 gene expression in the peripheral blood: the Hungarian experience. Pediatr Hematol Oncol 2003; 20: 65–74
   PubMed Web of Science ®Google Scholar
• Miwa H, Beran M, Saunders G F. Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 1992; 6: 405–409
   PubMed Web of Science ®Google Scholar
• Omran H, Shabani M, Vossough P, Sharifian R, Tabrizi M, Khoshnoodi J, et al. Cross-sectional monitoring of Wilms' tumor gene 1 (WT1) expression in Iranian patients with acute lymphoblastic leukemia at diagnosis, relapse and remission. Leuk Lymphoma 2008; 49: 281–290
   PubMed Web of Science ®Google Scholar
• Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 1994; 84: 3071–3079
   PubMed Web of Science ®Google Scholar
• Gaiger A, Schmid D, Heinze G, Linnerth B, Greinix H, Kalhs P, et al. Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia. Leukemia 1998; 12: 1886–1894
   PubMed Web of Science ®Google Scholar
• Spanaki A, Linardakis E, Perdikogianni C, Stiakaki E, Morotti A, Cilloni D, et al. Quantitative assessment of WT1 expression in diagnosis of childhood acute leukemia. Leuk Res 2007; 31: 570–572
   PubMed Web of Science ®Google Scholar
• Ludwig W D, Rieder H, Bartram C R, Heinze B, Schwartz S, Gassmann W, et al. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. Blood 1998; 92: 1898–1909
   PubMed Web of Science ®Google Scholar
• Borkhardt A, Wuchter C, Viehmann S, Pils S, Teigler-Schlegel A, Stanulla M, et al. Infant acute lymphoblastic leukemia – combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Leukemia 2002; 16: 1685–1690
   PubMed Web of Science ®Google Scholar